留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
中华医学会器官移植学分会, 国家肺移植质量管理与控制中心. 中国肺移植供体标准及获取转运指南[J]. 器官移植, 2018, 9(5): 325-333. doi: 10.3969/j.issn.1674-7445.2018.05.001
引用本文: 中华医学会器官移植学分会, 国家肺移植质量管理与控制中心. 中国肺移植供体标准及获取转运指南[J]. 器官移植, 2018, 9(5): 325-333. doi: 10.3969/j.issn.1674-7445.2018.05.001
Branch of Organ Transplantation of Chinese Medical Association, National Quality Management and Control Center for Lung Transplantation. Guideline on the standard of lung transplantation donors and the acquisition and transshipment in China[J]. ORGAN TRANSPLANTATION, 2018, 9(5): 325-333. doi: 10.3969/j.issn.1674-7445.2018.05.001
Citation: Branch of Organ Transplantation of Chinese Medical Association, National Quality Management and Control Center for Lung Transplantation. Guideline on the standard of lung transplantation donors and the acquisition and transshipment in China[J]. ORGAN TRANSPLANTATION, 2018, 9(5): 325-333. doi: 10.3969/j.issn.1674-7445.2018.05.001

中国肺移植供体标准及获取转运指南

doi: 10.3969/j.issn.1674-7445.2018.05.001
基金项目: 

中国人体器官捐献管理中心人体器官捐献专项研究课题;江苏省科教强卫工程青年医学重点人才项目 QNRC2016193

详细信息
    通讯作者:

    陈静瑜,男,1963年生,主任医师,研究方向为胸外科,Email:chenjingyu333@sina.com

  • 中图分类号: R617, R563

Guideline on the standard of lung transplantation donors and the acquisition and transshipment in China

  • 摘要: 2015年我国供肺利用率仅约5%。从器官获取组织(OPO)进行供肺协调、初步评估和维护,到供肺获取直至最后经民航、高速公路、高铁转运完成肺移植,每一环节都相当艰难。许多初评合格的供肺,由于缺乏有效的维护而无法用于移植。因此,我们组织专家制订我国肺移植供体标准及获取转运指南,从我国肺移植供肺捐献的分类、供肺选择标准、供肺维护策略、供肺获取流程、供肺转运流程等方面,总结我国肺移植的临床实践经验,希望能为肺移植相关临床科室提供工作指引。
  • 图  1  供肺灌注示意图

    Figure  1.  Diagram of donor lung perfusion

    图  2  心肺分离示意图(保留供肺心房袖)

    Figure  2.  Diagram of cardiopulmonary separation (preservation of atrial sleeve of donor lung)

    图  3  修剪后的供肺示意图

    A图为双侧供肺;B图为心肺分离;C图为双肺分离成左、右单肺;D图为修剪后的左、右供肺

    Figure  3.  Diagram of pruned donor lung

    图  4  供肺转运流程图

    Figure  4.  Flow chart of donor lung transport

  • [1] NATHAN SD. The future of lung transplantation[J]. Chest, 2015, 147(2): 309-316. DOI: 10.1378/chest.14-1748.
    [2] 陈静瑜.肺移植供体肺的维护及获取[J].武汉大学学报(医学版), 2016, 37(4): 540-542. DOI: 10.14188/j.1671-8852.2016.04.006.

    CHEN JY. The maintenance and acquisition of donor lung in lung transplantation[J]. Med J Wuhan Univ, 2016, 37(4): 540-542. DOI: 10.14188/j.1671-8852.2016.04.006.
    [3] VALAPOUR M, SKEANS MA, HEUBNER BM, et al. OPTN/SRTR 2013 annual data report: lung[J]. Am J Transplant, 2015, 15(Suppl 2): 1-28. DOI: 10.1111/ajt.13200.
    [4] MAO WJ, CHEN JY. Difficulties and countermeasures of lung transplantation in China [J/CD]. Chin J Thorac Surg, 2016, 3(1): 1-6. DOI: 10.3877/cma.j.issn.2095-8773.2016.01.001.
    [5] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会.中国活体供肾移植临床指南(2016版)[J].器官移植, 2016, 7(6): 417-426. DOI: 10.3969/j.issn.1674-7445.2016.06.002.

    Branch of Organ Transplantation of Chinese Medical Association, Branch of Organ Transplant Physician of Chinese Medical Doctor Association. Clinical guideline on living donor renal transplantation in China (2016 Edition)[J]. Organ Transplant, 2016, 7(6): 417-426. DOI: 10.3969/j.issn.1674-7445.2016.06.002.
    [6] 卫生部医管司. 卫生部办公厅关于启动心脏死亡捐献器官移植试点工作的通知: 中国心脏死亡器官捐献分类标准[EB/OL]. [2011-05-03]. http://www.nhfpc.gov.cn/yzygj/s3586q/201105/03ddc86c0d974c058832807f7414d596.shtml.
    [7] 国家卫生和计划生育委员会脑损伤质控评价中心.脑死亡判定标准与技术规范(成人质控版)[J].中华神经科杂志, 2013, 46(9): 637-640. DOI: 10.3760/cma.j.issn.1006-7876.2013.09.015.

    Brain Injury Evaluation Quality Control Centre of National Health and Family Planning Commission. Judgment criteria and technical regulations of cerebral death (Adult quality control Edition) [J]. Chin J Neurol, 2013, 46(9): 637-640. DOI: 10.3760/cma.j.issn.1006-7876.2013.09.015.
    [8] 中华医学会器官移植学分会.中国心脏死亡器官捐献工作指南(第2版)[J].中华器官移植杂志, 2011, 32(12): 756-758. DOI: 10.3760/cma.j.issn.0254-1785.2011.12.014.

    Branch of Organ Transplantation of Chinese Medical Association. Work guideline of donation after cardiac death in China (2nd Edition)[J]. Chin J Organ Transplant, 2011, 32(12): 756-758. DOI: 10.3760/cma.j.issn.0254-1785.2011.12.014.
    [9] SNELL GI, PARASKEVA M, WESTALL GP. Donor selection and management[J]. Semin Respir Crit Care Med, 2013, 34(3): 361-370. DOI: 10.1055/s-0033-1348464.
    [10] BALDWIN MR, PETERSON ER, EASTHAUSEN I, et al. Donor age and early graft failure after lung transplantation: a cohort study[J]. Am J Transplant, 2013, 13(10): 2685-2695. DOI: 10.1111/ajt.12428.
    [11] BONSER RS, TAYLOR R, COLLETT D, et al. Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry[J]. Lancet, 2012, 380(9843): 747-755. DOI: 10.1016/S0140-6736(12)60160-3.
    [12] CHANEY J, SUZUKI Y, CANTU E 3RD, et al. Lung donor selection criteria[J]. J Thorac Dis, 2014, 6(8): 1032-1038. DOI: 10.3978/j.issn.2072-1439.2014.03.24.
    [13] 王振兴, 陈静瑜, 郑明峰, 等.肺移植供肺获取100例:冷缺血时间 > 6 h及肺减容对预后的影响[J].中国组织工程研究, 2012, 16(5): 835-838. DOI: 10.3969/j.issn.1673-8225.2012.05.018.

    WANG ZX, CHEN JY, ZHENG MF, et al. 100 cases of lung harvesting for lung transplantation: effect of cold ischemia time > 6 hours and lung volume reduction on prognosis[J]. Chin J Tissue Eng Res, 2012, 16(5): 835-838. DOI: 10.3969/j.issn.1673-8225.2012.05.018.
    [14] GAMMIE JS, STUKUS DR, PHAM SM, et al. Effect of ischemic time on survival in clinical lung transplantation[J]. Ann Thorac Surg, 1999, 68(6): 2015-2020. doi: 10.1016/S0003-4975(99)00903-0
    [15] ORENS JB, BOEHLER A, DE PERROT M, et al. A review of lung transplant donor acceptability criteria[J]. J Heart Lung Transplant, 2003, 22(11): 1183-1200. doi: 10.1016/S1053-2498(03)00096-2
    [16] STUDER SM, ORENS JB. Cadaveric donor selection and management[J]. Semin Respir Crit Care Med, 2006, 27(5):492-500. doi: 10.1055/s-2006-954607
    [17] VAN RAEMDONCK D, NEYRINCK A, VERLEDEN GM, et al. Lung donor selection and management[J]. Proc Am Thorac Soc, 2009, 6(1): 28-38. DOI: 10.1513/pats.200808-098GO.
    [18] MULVIHILL MS, GULACK BC, GANAPATHI AM, et al. The association of donor age and survival is independent of ischemic time following deceased donor lung transplantation[J]. Clin Transplant, 2017, 31(7). DOI: 10.1111/ctr.12993.
    [19] CHAMBERS DC, YUSEN RD, CHERIKH WS, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time[J]. J Heart Lung Transplant, 2017, 36(10): 1047-1059. DOI: 10.1016/j.healun.2017.07.016.
    [20] HAYES D JR, HARTWIG MG, TOBIAS JD, et al. Lung transplant center volume ameliorates adverse influence of prolonged ischemic time on mortality[J]. Am J Transplant, 2017, 17(1): 218-226. DOI: 10.1111/ajt.13916.
    [21] SNELL GI, WESTALL GP. Selection and management of the lung donor[J]. Clin Chest Med, 2011, 32(2):223-232. DOI: 10.1016/j.ccm.2011.02.002.
    [22] 马春林, 梁道业, 郑福奎.高呼气末正压在神经源性肺水肿机械通气中的作用[J].中华危重病急救医学, 2014, 26(5): 339-342. DOI: 10.3760/cma.j.issn.2095-4352.2014.05.011.

    MA CL, LIANG DY, ZHENG FK. Effect of high positive end-expiratory pressure for mechanical ventilation in the treatment of neurological pulmonary edema[J]. Chin Crit Care Med, 2014, 26(5): 339-342. DOI: 10.3760/cma.j.issn.2095-4352.2014.05.011.
    [23] 冯艳, 于国东, 王华, 等.神经源性肺水肿的液体治疗策略探讨[J].中华神经医学杂志, 2015, 14(2): 176-180. DOI: 10.3760/cma.j.issn.1671-8925.2015.02.015.

    FENG Y, YU GD, WANG H, et al. Fluid management in patients with neurogenic pulmonary edema[J]. Chin J Neuromed, 2015, 14(2): 176-180. DOI: 10.3760/cma.j.issn.1671-8925.2015.02.015.
    [24] MIÑAMBRES E, RODRIGO E, BALLESTEROS MA, et al. Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation[J]. Nephrol Dial Transplant, 2010, 25(7): 2352-2356. DOI: 10.1093/ndt/gfq054.
    [25] MUNSHI L, KESHAVJEE S, CYPEL M. Donor management and lung preservation for lung transplantation[J]. Lancet Respir Med, 2013, 1(4): 318-328. DOI: 10.1016/S2213-2600(12)70064-4.
    [26] PENNEFATHER SH, BULLOCK RE, MANTLE D, et al. Use of low dose arginine vasopressin to support brain-dead organ donors[J]. Transplantation, 1995, 59(1): 58-62. doi: 10.1097/00007890-199501150-00011
    [27] TUTTLE-NEWHALL JE, COLLINS BH, KUO PC, et al. Organ donation and treatment of the multi-organ donor[J]. Curr Probl Surg, 2003, 40(5): 266-310. doi: 10.1067/msg.2003.120005
    [28] DETERMANN RM, ROYAKKERS A, WOLTHUIS EK, et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial[J]. Crit Care, 2010, 14(1):R1. DOI: 10.1186/cc8230.
    [29] MASCIA L, PASERO D, SLUTSKY AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial[J]. JAMA, 2010, 304(23): 2620-2627. DOI: 10.1001/jama.2010.1796.
    [30] HOWLETT TA, KEOGH AM, PERRY L, et al. Anterior and posterior pituitary function in brain-stem-dead donors. a possible role for hormonal replacement therapy[J]. Transplantation, 1989, 47(5): 828-834. doi: 10.1097/00007890-198905000-00016
    [31] SHEMIE SD, ROSS H, PAGLIARELLO J, et al. Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential[J]. CMAJ, 2006, 174(6):S13-S32. doi: 10.1503/cmaj.045131
    [32] DIMOPOULOU I, TSAGARAKIS S, ANTHI A, et al. High prevalence of decreased cortisol reserve in brain-dead potential organ donors[J]. Crit Care Med, 2003, 31(4): 1113-1117. doi: 10.1097/01.CCM.0000059644.54819.67
    [33] FOLLETTE DM, RUDICH SM, BABCOCK WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death[J]. J Heart Lung Transplant, 1998, 17(4): 423-429.
    [34] MACDONALD PS, ANEMAN A, BHONAGIRI D, et al. A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors[J]. Crit Care Med, 2012, 40(5): 1635-1644. DOI: 10.1097/CCM.0b013e3182416ee7.
    [35] ARNAOUTAKIS GJ, ALLEN JG, MERLO CA, et al. Low potassium dextran is superior to university of Wisconsin solution in high-risk lung transplant recipients[J]. J Heart Lung Transplant, 2010, 29(12): 1380-1387. DOI: 10.1016/j.healun.2010.05.031.
    [36] THABUT G, VINATIER I, BRUGIÈRE O, et al. Influence of preservation solution on early graft failure in clinical lung transplantation[J]. Am J Respir Crit Care Med, 2001, 164(7): 1204-1208. doi: 10.1164/ajrccm.164.7.2012135
    [37] SASAKI M, MURAOKA R, CHIBA Y, et al. Influence of pulmonary arterial pressure during flushing on lung preservation[J]. Transplantation, 1996, 61(1): 22-27. doi: 10.1097/00007890-199601150-00006
    [38] VENUTA F, RENDINA EA, BUFI M, et al. Preimplantation retrograde pneumoplegia in clinical lung transplantation[J]. J Thorac Cardiovasc Surg, 1999, 118(1): 107-114. doi: 10.1016/S0022-5223(99)70149-2
    [39] VAN DE WAUWER C, NEYRINCK AP, GEUDENS N, et al. Retrograde flush following warm ischemia in the non-heart-beating donor results in superior graft performance at reperfusion[J]. J Surg Res, 2009, 154(1): 118-125. DOI: 10.1016/j.jss.2008.06.007.
    [40] KAYANO K, TODA K, NAKA Y, et al. Identification of optimal conditions for lung graft storage with Euro-Collins solution by use of a rat orthotopic lung transplant model[J]. Circulation, 1999, 100(19 Suppl): II257- II261. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=WK_LWW201705250306999
  • 加载中
图(4)
计量
  • 文章访问数:  16
  • HTML全文浏览量:  4
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-08-03
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2018-09-15

目录

    /

    返回文章
    返回